In vivo Tumor Growth and Spontaneous Metastasis Assays Using A549 Lung Cancer Cells

Lei Qi; Teresa Knifley; Dava W. Piecoro; Piotr Rychahou; Jianrong Wu; Kathleen L. O’Connor; Min Chen

doi:10.21769/BioProtoc.3579

In vivo Tumor Growth and Spontaneous Metastasis Assays Using A549 Lung Cancer Cells

Lei Qi, Teresa Knifley, Dava W. Piecoro, Piotr Rychahou, Jianrong Wu, Kathleen L. O’Connor, Min Chen

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

Metastasis accounts for the majority of cancer related deaths. The genetically engineered mouse (GEM) models and cell line-based subcutaneous and orthotopic mouse xenografts have been developed to study the metastatic process. By using lung cancer cell line A549 as an example, we present a modified protocol to establish the cell line-based xenograft. Our protocol ensures sufficient establishment of the mouse xenografts and allows us to monitor tumor growth and spontaneous metastasis. This protocol could be adapted to other types of established cancer cell lines or primary cancer cells to study the mechanism of metastatic process as well as to test the effect of the potential anti-cancer agents on tumor growth and metastatic capacity.

Original language	English
Article number	e3579
Journal	Bio-protocol
Volume	10
Issue number	7
DOIs	https://doi.org/10.21769/BioProtoc.3579
State	Published - Apr 5 2020

Bibliographical note

Publisher Copyright:
Copyright © 2020 The Authors; exclusive licensee Bio-protocol LLC.

Keywords

Cell line xenograft
Implantation
Metastasis rate
Mouse
Patient-derived xenograft
Tumor growth

ASJC Scopus subject areas

General Neuroscience
General Biochemistry, Genetics and Molecular Biology
General Immunology and Microbiology
Plant Science

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.21769/BioProtoc.3579

Cite this

@article{a96337c41da748fb9d03d7fe9465c84e,

title = "In vivo Tumor Growth and Spontaneous Metastasis Assays Using A549 Lung Cancer Cells",

abstract = "Metastasis accounts for the majority of cancer related deaths. The genetically engineered mouse (GEM) models and cell line-based subcutaneous and orthotopic mouse xenografts have been developed to study the metastatic process. By using lung cancer cell line A549 as an example, we present a modified protocol to establish the cell line-based xenograft. Our protocol ensures sufficient establishment of the mouse xenografts and allows us to monitor tumor growth and spontaneous metastasis. This protocol could be adapted to other types of established cancer cell lines or primary cancer cells to study the mechanism of metastatic process as well as to test the effect of the potential anti-cancer agents on tumor growth and metastatic capacity.",

keywords = "Cell line xenograft, Implantation, Metastasis rate, Mouse, Patient-derived xenograft, Tumor growth",

author = "Lei Qi and Teresa Knifley and Piecoro, {Dava W.} and Piotr Rychahou and Jianrong Wu and O{\textquoteright}Connor, {Kathleen L.} and Min Chen",

note = "Publisher Copyright: Copyright {\textcopyright} 2020 The Authors; exclusive licensee Bio-protocol LLC.",

year = "2020",

month = apr,

day = "5",

doi = "10.21769/BioProtoc.3579",

language = "English",

volume = "10",

number = "7",

}

TY - JOUR

T1 - In vivo Tumor Growth and Spontaneous Metastasis Assays Using A549 Lung Cancer Cells

AU - Qi, Lei

AU - Knifley, Teresa

AU - Piecoro, Dava W.

AU - Rychahou, Piotr

AU - Wu, Jianrong

AU - O’Connor, Kathleen L.

AU - Chen, Min

PY - 2020/4/5

Y1 - 2020/4/5

N2 - Metastasis accounts for the majority of cancer related deaths. The genetically engineered mouse (GEM) models and cell line-based subcutaneous and orthotopic mouse xenografts have been developed to study the metastatic process. By using lung cancer cell line A549 as an example, we present a modified protocol to establish the cell line-based xenograft. Our protocol ensures sufficient establishment of the mouse xenografts and allows us to monitor tumor growth and spontaneous metastasis. This protocol could be adapted to other types of established cancer cell lines or primary cancer cells to study the mechanism of metastatic process as well as to test the effect of the potential anti-cancer agents on tumor growth and metastatic capacity.

AB - Metastasis accounts for the majority of cancer related deaths. The genetically engineered mouse (GEM) models and cell line-based subcutaneous and orthotopic mouse xenografts have been developed to study the metastatic process. By using lung cancer cell line A549 as an example, we present a modified protocol to establish the cell line-based xenograft. Our protocol ensures sufficient establishment of the mouse xenografts and allows us to monitor tumor growth and spontaneous metastasis. This protocol could be adapted to other types of established cancer cell lines or primary cancer cells to study the mechanism of metastatic process as well as to test the effect of the potential anti-cancer agents on tumor growth and metastatic capacity.

KW - Cell line xenograft

KW - Implantation

KW - Metastasis rate

KW - Mouse

KW - Patient-derived xenograft

KW - Tumor growth

UR - http://www.scopus.com/inward/record.url?scp=85125646811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85125646811&partnerID=8YFLogxK

U2 - 10.21769/BioProtoc.3579

DO - 10.21769/BioProtoc.3579

M3 - Article

AN - SCOPUS:85125646811

VL - 10

JO - Bio-protocol

JF - Bio-protocol

IS - 7

M1 - e3579

ER -

In vivo Tumor Growth and Spontaneous Metastasis Assays Using A549 Lung Cancer Cells

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this